Strategic Collaborators

Collaboration is an integral part of our success. Our alliances with pharmaceutical and biotech companies, government organizations, foundations and research institutes are helping us deliver medicines to the MENA countries

New Opportunities

Riverside Research is actively negotiating with global pharmaceutical companies on in-licensing targeted agents that our Scientific Advisory Board have identified as therapeutically relevant and in therapeutic areas where similar agents are in short supply or on demand in the GCC and MENA market.
We are currently exploring opportunities in the following therapeutic areas:

⦁ Oncology
⦁ Vaccines
⦁ Autoimmune diseases
⦁ Brain diseases (Parkinson’s disease, Alzheimer’s disease, Stroke)